Opportunity Information: Apply for RFA NS 12 001
Apply for RFA NS 12 001
- The National Institutes of Health in the education environment food and nutrition health income security and social services sector is offering a public funding opportunity titled "NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113 Environmental Health 93.121 Oral Diseases and Disorders Research 93.142 NIEHS Hazardous Waste Worker Health and Safety Training 93.143 NIEHS Superfund Hazardous SubstancesBasic Research and Education 93.172 Human Genome Research 93.173 Research Related to Deafness and Communication Disorders 93.213 Research and Training in Complementary and Integrative Health 93.233 National Center on Sleep Disorders Research 93.242 Mental Health Research Grants 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.307 Minority Health and Health Disparities Research 93.361 Nursing Research 93.389 National Center for Research Resources 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control 93.837 Cardiovascular Diseases Research 93.838 Lung Diseases Research 93.846 Arthritis, Musculoskeletal and Skin Diseases Research 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.855 Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research 93.859 Biomedical Research and Research Training 93.865 Child Health and Human Development Extramural Research 93.866 Aging Research 93.867 Vision Research 93.879 Medical Library Assistance 93.989 International Research and Research Training.
- This funding opportunity was created on Dec 8, 2010 and posted on Dec 8, 2010.
- Applicants must submit their applications by Apr 11, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: State governments Special district governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Independent school districts Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25) funding opportunity (RFA-NS-12-001) is a discretionary NIH grant program designed to support the creation and delivery of short, intensive educational courses that teach academic neuroscientists how to move from basic neuroscience discoveries toward practical treatments. The focus is not on funding a specific therapeutic project, but on building the knowledge and skills that researchers need to understand the full development pathway for neurotherapeutics and to work effectively with the many specialized partners typically required to translate research into interventions that can ultimately benefit patients.
At its core, this FOA asks applicant organizations to develop and implement short courses that give participants a broad but meaningful overview of neurotherapeutics development. The training is expected to help attendees understand the major stages involved in developing therapies (from early discovery and target selection through preclinical development and later translational steps), recognize common failure points and practical challenges (for example, issues related to experimental rigor, reproducibility, safety, feasibility, regulatory expectations, or go/no-go decision-making), and learn how to communicate and collaborate with experts across disciplines. In other words, the program aims to make academic researchers more fluent in the language, process, and problem-solving approach of therapeutic development so they can either integrate it into their own research programs or engage productively with collaborators who do.
The intended audience is primarily independent academic neuroscience researchers and senior postdoctoral fellows who are considering, or already beginning, to incorporate treatment development into their work. This emphasis reflects a translational gap the NIH has long recognized: many investigators have strong training in basic mechanisms but limited exposure to the practical realities of developing drugs, biologics, devices, or other therapeutic strategies. By supporting structured, well-designed short courses, the NIH Blueprint seeks to expand the community of neuroscientists who can help push promising findings toward real-world therapeutic opportunities.
The program uses the NIH Research Education Grant mechanism (R25), which is specifically meant to support educational activities that complement traditional research training and are aligned with NIH priorities. The FOA lists an award ceiling of $250,000 and indicates there is no cost-sharing or matching requirement. The opportunity was posted December 8, 2010, with an original and current closing date of April 11, 2011, and it was archived May 12, 2011, meaning it was time-limited and is no longer open under that specific announcement. Even so, the description is a useful model of the kinds of translational education NIH has sought to promote in neuroscience.
Eligibility is broad and includes many types of U.S.-based organizations that can credibly design and run high-quality educational programs. Eligible applicants include public and private institutions of higher education, nonprofits (including 501(c)(3) organizations), for-profit organizations (with distinctions noted for small businesses), state and local governments, tribal governments and tribal organizations, public housing authorities, independent school districts, and a range of special categories such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, U.S. territories or possessions, regional organizations, and faith-based or community-based organizations. This breadth signals NIH interest in encouraging diverse institutions and training environments to contribute to workforce development in neurotherapeutics.
The sponsoring agency is the National Institutes of Health under the NIH Blueprint for Neuroscience Research, and the listing is associated with multiple CFDA program areas across NIH, reflecting the cross-cutting, trans-NIH nature of the Blueprint and the wide relevance of therapeutics development training to many health and disease areas. For additional details, the full announcement was hosted on the NIH Grants Guide website (the FOA link provided in the source data), and NIH’s Office of Extramural Research (OER) webmaster contacts were listed for technical access and linking issues.
FAQs: NIH Blueprint Short Courses in Neurotherapeutics Development (R25) (RFA-NS-12-001)
What is the NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25) opportunity?
This funding opportunity (RFA-NS-12-001) is an NIH discretionary grant program that supports the development and delivery of short, intensive educational courses focused on neurotherapeutics development. It is designed to teach academic neuroscientists how to move from basic neuroscience discoveries toward practical treatments by understanding the overall development pathway and how to work effectively with specialized partners.
What is the primary goal of this program?
The main goal is workforce development and skills-building in translational science. Rather than funding a specific therapeutic project, the program funds structured short courses that help researchers become more fluent in the process, language, and practical problem-solving involved in developing neurotherapeutics that could ultimately benefit patients.
Does this grant fund a specific drug or therapeutic project?
No. The focus is not on supporting a particular neurotherapeutic development project. The emphasis is on creating and implementing educational short courses that teach the end-to-end pathway of neurotherapeutics development and the real-world challenges that can affect translation.
What types of educational activities are supported?
The FOA supports the creation and delivery of short, intensive educational courses. These courses are expected to provide a broad but meaningful overview of neurotherapeutics development and prepare participants to engage productively in translational work or collaborations.
What topics are the short courses expected to cover?
Courses are expected to address major stages of therapy development, from early discovery and target selection through preclinical development and later translational steps. They should also highlight common failure points and practical challenges, such as experimental rigor and reproducibility, safety considerations, feasibility issues, regulatory expectations, and go/no-go decision-making. Another key topic is effective communication and collaboration across disciplines.
Who is the intended audience for these courses?
The primary audience is independent academic neuroscience researchers and senior postdoctoral fellows who are considering, or already beginning, to incorporate treatment development into their research.
Why is NIH supporting short courses in neurotherapeutics development?
The FOA reflects a translational gap NIH has recognized: many investigators are well trained in basic neuroscience mechanisms but have limited exposure to the practical realities of developing drugs, biologics, devices, or other therapeutic strategies. The program aims to expand the community of neuroscientists equipped to move promising findings toward real-world therapeutic opportunities.
What grant mechanism is used for this program?
The program uses the NIH Research Education Grant mechanism (R25), which supports educational activities that complement traditional research training and align with NIH priorities.
What is the maximum award amount (award ceiling)?
The FOA lists an award ceiling of $250,000.
Is cost sharing or matching required?
No. The FOA indicates there is no cost-sharing or matching requirement.
When was this funding opportunity posted, and what were the closing dates?
The opportunity was posted on December 8, 2010. The original and current closing date listed was April 11, 2011.
Is this funding opportunity still open?
No. The announcement was archived on May 12, 2011, which indicates it was time-limited and is no longer open under that specific FOA (RFA-NS-12-001).
Who sponsors this program?
The sponsoring agency is the National Institutes of Health (NIH), under the NIH Blueprint for Neuroscience Research. The Blueprint is described as trans-NIH and cross-cutting, reflecting broad relevance across multiple NIH program areas.
What kinds of organizations are eligible to apply?
Eligibility is broad and includes many U.S.-based organizations capable of designing and running high-quality educational programs. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including 501(c)(3) entities), for-profit organizations (with distinctions noted for small businesses), state and local governments, tribal governments and tribal organizations, public housing authorities, and independent school districts.
Are any special categories of institutions explicitly included as eligible?
Yes. The FOA explicitly includes categories such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, U.S. territories or possessions, regional organizations, and faith-based or community-based organizations.
What does the broad eligibility suggest about NIH priorities?
The wide range of eligible organization types signals interest in encouraging diverse institutions and training environments to contribute to workforce development in neurotherapeutics development.
What is meant by "neurotherapeutics development" in this context?
In this FOA, neurotherapeutics development refers to the pathway and practical steps involved in translating neuroscience discoveries toward interventions, including drugs, biologics, devices, or other therapeutic strategies. The emphasis is on understanding the overall development process and its challenges rather than executing a specific product development effort within the grant.
What kinds of challenges or "failure points" are participants expected to learn about?
The FOA highlights practical challenges such as experimental rigor, reproducibility, safety, feasibility, regulatory expectations, and structured go/no-go decision-making as areas where translational efforts often encounter problems and where better understanding can improve outcomes.
Where were additional details provided for this opportunity?
The full announcement was hosted on the NIH Grants Guide website (via the FOA link referenced in the source data). NIH Office of Extramural Research (OER) webmaster contacts were listed for technical access and linking issues.
What is the value of this archived FOA today?
Even though it is no longer open, the description can serve as a useful model for the kinds of translational education NIH has sought to promote in neuroscience, particularly education that helps bridge basic discovery and therapeutic development.
Browse more opportunities from the same category: Education Environment Food and Nutrition Health Income Security and Social Services
Next opportunity: NIA Program Project Applications (P01)
Previous opportunity: Advanced In Vivo Imaging to Understand Cancer Systems (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NS 12 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NS 12 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| PHS 2011 02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42) Apply for PA 11 097 Funding Number: PA 11 097 Agency: National Institutes of Health Category: Education Environment Food and Nutrition Health Income Security and Social Services Funding Amount: $100,000 |
| PHS 2011 02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR R43/R44) Apply for PA 11 096 Funding Number: PA 11 096 Agency: National Institutes of Health Category: Education Environment Food and Nutrition Health Income Security and Social Services Funding Amount: $150,000 |
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships to Promote Diversity in Health Related Research (Parent F31 Diversity) Apply for PA 11 112 Funding Number: PA 11 112 Agency: National Institutes of Health Category: Education Environment Food and Nutrition Health Income Security and Social Services Funding Amount: Case Dependent |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (Parent T32) Apply for PA 11 184 Funding Number: PA 11 184 Agency: National Institutes of Health Category: Education Environment Food and Nutrition Health Income Security and Social Services Funding Amount: Case Dependent |
| Genetic Screens to Enhance Zebrafish Research (R01) Apply for PAR 11 130 Funding Number: PAR 11 130 Agency: National Institutes of Health Category: Education Environment Food and Nutrition Health Income Security and Social Services Funding Amount: $500,000 |
| Enhancing Zebrafish Research with Research Tools and Techniques (R01) Apply for PAR 11 131 Funding Number: PAR 11 131 Agency: National Institutes of Health Category: Education Environment Food and Nutrition Health Income Security and Social Services Funding Amount: Case Dependent |
| Midcareer Investigator Award in Patient Oriented Research (Parent K24) Apply for PA 11 195 Funding Number: PA 11 195 Agency: National Institutes of Health Category: Education Environment Food and Nutrition Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 12 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.